BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 2, 2016
View Archived Issues
Vimpat launched in Japan as adjunctive therapy for partial onset seizures
Read More
AstraZeneca and Aspen complete anesthetics commercialization agreement
Read More
FDA grants fast track designation to APL-130277 to treat off episodes in Parkinson's disease
Read More
Pfizer presents data on new JAK1/TYK2 inhibitor
Read More
Genetech discloses KDM5 inhibitors for the potential treatment of cancer
Read More
Genentech describes new CREB-binding protein inhibitors
Read More
Shanghai De Novo Pharmatech patents IDO1 and/or TOD2 inhibitors
Read More
Genentech and Roche disclose TRPA1 antagonists
Read More
Enanta Pharmaceuticals describes FXR agonists
Read More
Merck & Co. develops retinoid RORgammaT antagonists
Read More
Incyte announces PI3Kgamma inhibitors
Read More
Johns Hopkins and Salk co-lead an initiative to advance bipolar disorder and schizophrenia research
Read More
PCI Biotech and BioNTech establish preclinical research collaboration
Read More
FDA approves Blincyto for pediatric patients with Ph-negative B-cell precursor ALL
Read More
FDA awards fast track designation to aducanumab in Alzheimer's disease
Read More
Omecamtiv mecarbil enters phase III clinical development
Read More
Chugai transfers the manufacturing and marketing rights for Vesanoid
Read More
Myriad Genetics completes Assurex Health acquisition
Read More
AdAlta receives grant for the development of AD-114 in IPF
Read More
FDA accepts Array's NDA for binimetinib
Read More
Lytix's LYX-315 studied at Massachusetts General Hospital and Harvard Medical School
Read More
BARDA selects Takeda Vaccines for the development of Zika vaccine
Read More
European Commission approves expanded use of Xultophy
Read More
Alnylam's ALN-AS1 receives FDA orphan drug designation
Read More
TLR4 expression predicts response to immunosuppressive therapy in patients with myocarditis
Read More
University of Dundee, GlaxoSmithKline develop novel compound for leishmaniasis
Read More
New microRNAs linked to 10-year risk of fatal myocardial infarction
Read More
Genmab wins sBLA for ofatumumab in CLL
Read More
SAGE-217 shows promise for seizure disorders
Read More